Belsomra generic date?

When Can You Expect Belsomra to Become Available as a Generic?

The U.S. patent expiry for Belsomra (suvorexant) is projected for [1] 2024 according to DrugPatentWatch.com [1][2]. This means that generic versions of the medication could potentially become available in the market around that time [1].

What Does Patent Expiry Mean for Belsomra's Availability?

Once patents expire, other pharmaceutical companies are generally able to develop and market generic versions of the drug. This typically leads to increased competition and a reduction in the drug's price for consumers [3].

What is Belsomra Used For?

Belsomra is a prescription medication used to treat insomnia characterized by difficulties with sleep onset and/or sleep maintenance [4]. It works by blocking the activity of orexins, neuropeptides that play a role in keeping you awake [4].